FDA
-
-
-
-
-
-
-
RedHill Biopharma regains NASDAQ stockholders' equity compliance
-
-
-
-
-
-
-
RedHill Biopharma Receives Nasdaq Staff Determination Notification
-
-
-
-
-
-
-
RedHill Biopharma wins $10 million court judgment on appeal
-
-
-
-
-
-
-
RedHill gets FDA guidance for Crohn's disease drug trial design
-
-
-
-
-
-
-
RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107
-
-
-
-
-
-
-
RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation
-
-
-
-
-
-
-
RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

